<?xml version="1.0" encoding="UTF-8"?>
<p>The use of intravenous ACE inhibitors and ARB in experimental animals increases ACE2 expression in the cardiopulmonary circulation systems, causing a possible increased risk for SARS-CoV-2 infection.
 <sup>
  <xref rid="bibr56-0004563220928361" ref-type="bibr">56</xref>
 </sup> Severe COVID-19 outcomes were described in patients with existing hypertension, coronary artery disease, diabetes and chronic kidney disease.
 <sup>
  <xref rid="bibr57-0004563220928361" ref-type="bibr">57</xref>
 </sup> The question was asked whether their current treatment regimens were increasing their risk for infection.
</p>
